Insider · CIK 0001677141
Sandip Kapadia
Files at PASG (Passage BIO, Inc.), HRMY (Harmony Biosciences Holdings, Inc.). First filing Jan 23, 2025, latest Jan 28, 2026.
In brief
Sandip Kapadia files SEC Form 4 as CFO and director at HRMY (Harmony Biosciences Holdings, Inc.), and also at PASG (Passage BIO, Inc.). Since Jan 23, 2025, Sandip Kapadia has reported 0 open-market buys worth $0 and 8 open-market sells worth $3.9M, the latest filed on Jan 28, 2026.
A track record needs three past buys with six months of prices behind them; Sandip Kapadia has 0, so none is measured yet.
The newest scored trade: sold $139k of HRMY on Jan 26, 2026, filed Jan 28, 2026, scored 18 (weak), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 4 sells worth $1.8M.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
HRMY: Harmony Biosciences Holdings, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 18Weak | Harmony Biosciences Holdings, Inc. | $139k 3,746 shares | -13% | +44% from low-8% from high | |
| 44Moderate | Harmony Biosciences Holdings, Inc. | $753k 20,961 shares | -100% | +41% from low-10% from high | |
| 37Weak | Harmony Biosciences Holdings, Inc. | $791k 20,000 shares | -100% | +54% from low-2% from high | |
| 32Weak | Harmony Biosciences Holdings, Inc. | $120k 3,427 shares | -100% | +32% from low-15% from high | |
| 44Moderate | Harmony Biosciences Holdings, Inc. | $787k 21,573 shares | -100% | +32% from low-11% from high | |
| 35Weak | Harmony Biosciences Holdings, Inc. | $227k 6,987 shares | -100% | +2% from low-22% from high | |
| 30Weak | Harmony Biosciences Holdings, Inc. | $68k 1,775 shares | -100% | - | |
| 47Moderate | Harmony Biosciences Holdings, Inc. | $1.0M 25,000 shares | -100% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Jul 2, 2026 | HRMY HARMONY BIOSCIENCES HOLDINGS, INC. | 25,000 0.04% of outstanding | $924k | Jul 2, 2026 | $6.2M |
| Jun 30, 2026 | HRMY HARMONY BIOSCIENCES HOLDINGS, INC. | 50,000 0.09% of outstanding | $1.8M | Jun 30, 2026 | $4.4M |
| Jun 26, 2026 | HRMY HARMONY BIOSCIENCES HOLDINGS, INC. | 45,594 0.08% of outstanding | $1.6M | Jun 26, 2026 | $2.8M |
| Jun 24, 2026 | HRMY HARMONY BIOSCIENCES HOLDINGS, INC. | 4,406 0.01% of outstanding | $154k | Jun 24, 2026 | $2.7M |
| Jun 9, 2026 | HRMY HARMONY BIOSCIENCES HOLDINGS, INC. | 27,960 0.05% of outstanding | $943k | Jun 9, 2026 | $1.7M |
| Jun 5, 2026 | HRMY HARMONY BIOSCIENCES HOLDINGS, INC. | 2,101 0.00% of outstanding | $70k | Jun 5, 2026 | $1.7M |
| Jun 4, 2026 | HRMY HARMONY BIOSCIENCES HOLDINGS, INC. | 7,064 0.01% of outstanding | $233k | Jun 4, 2026 | $1.4M |
| May 8, 2026 | HRMY HARMONY BIOSCIENCES HOLDINGS, INC. | 45,481 0.08% of outstanding | $1.4M | May 8, 2026 | none |
| Jan 26, 2026 | HRMY HARMONY BIOSCIENCES HOLDINGS INC | 3,746 0.01% of outstanding | $138k | Jan 26, 2026 | $1.7M |
| Jan 15, 2026 | HRMY HARMONY BIOSCIENCES HOLDINGS,INC | 20,961 0.04% of outstanding | $755k | Jan 15, 2026 | $911k |
| Dec 5, 2025 | HRMY HARMONY BIOSCIENCES HLDGS INC | 20,000 0.03% of outstanding | $765k | Dec 5, 2025 | $120k |
| Nov 21, 2025 | HRMY HARMONY BIOSCIENCES HLDGS INC | 3,427 0.01% of outstanding | $114k | Nov 21, 2025 | none |
| Aug 15, 2025 | HRMY HARMONY BIOSCIENCES HLDGS INC | 21,573 0.04% of outstanding | $788k | Aug 15, 2025 | none |
| Apr 1, 2025 | HRMY HARMONY BIOSCIENCES HOLDINGS, INC. | 6,986 0.01% of outstanding | $232k | Apr 1, 2025 | $1.1M |
| Jan 27, 2025 | HRMY HARMONY BIOSCIENCES HOLDINGS, INC. | 1,775 0.00% of outstanding | $67k | Jan 27, 2025 | $1.0M |
| Jan 21, 2025 | HRMY HARMONY BIOSCIENCES HLDGS, INC. | 25,000 0.04% of outstanding | $976k | Jan 21, 2025 | none |
Transactions
Every row this insider has filed, 34 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 19, 2026 | PASG Passage BIO, Inc. | AGrant or award Director Stock Option (right to buy)derivative | +10,539 | $0.00 | $0 | 10,539 | May 21, 2026 |
| Jan 26, 2026 | HRMY Harmony Biosciences Holdings, Inc. | SOpen-market sale Common Stock10b5-1 | -3,746 | $37.15 | $139k | 24,521 | Jan 28, 2026 |
| Jan 24, 2026 | HRMY Harmony Biosciences Holdings, Inc. | MOption exercise Common Stock | +3,813 | $0.00 | $0 | 3,813 | Jan 26, 2026 |
| Jan 24, 2026 | HRMY Harmony Biosciences Holdings, Inc. | FTax withholding Common Stock | -2,239 | $36.82 | $82k | 1,574 | Jan 26, 2026 |
| Jan 25, 2026 | HRMY Harmony Biosciences Holdings, Inc. | MOption exercise Common Stock | +4,725 | $0.00 | $0 | 4,725 | Jan 26, 2026 |
| Jan 25, 2026 | HRMY Harmony Biosciences Holdings, Inc. | FTax withholding Common Stock | -2,553 | $36.82 | $94k | 2,172 | Jan 26, 2026 |
| Jan 22, 2026 | HRMY Harmony Biosciences Holdings, Inc. | AGrant or award Stock Optionderivative | +42,600 | $0.00 | $0 | 42,600 | Jan 26, 2026 |
| Jan 22, 2026 | HRMY Harmony Biosciences Holdings, Inc. | AGrant or award Restricted Stock Unitsderivative | +12,200 | $0.00 | $0 | 12,200 | Jan 26, 2026 |
| Jan 24, 2026 | HRMY Harmony Biosciences Holdings, Inc. | MOption exercise Restricted Stock Unitsderivative | -3,813 | $0.00 | $0 | 7,625 | Jan 26, 2026 |
| Jan 25, 2026 | HRMY Harmony Biosciences Holdings, Inc. | MOption exercise Restricted Stock Unitsderivative | -4,725 | $0.00 | $0 | 14,175 | Jan 26, 2026 |
| Jan 15, 2026 | HRMY Harmony Biosciences Holdings, Inc. | SOpen-market sale Common Stock10b5-1 | -20,961 | $35.92 | $753k | 0 | Jan 20, 2026 |
| Dec 5, 2025 | HRMY Harmony Biosciences Holdings, Inc. | MOption exercise Common Stock10b5-1 | +20,000 | $29.03 | $581k | 20,000 | Dec 9, 2025 |
| Dec 5, 2025 | HRMY Harmony Biosciences Holdings, Inc. | SOpen-market sale Common Stock10b5-1 | -20,000 | $39.54 | $791k | 0 | Dec 9, 2025 |
| Dec 5, 2025 | HRMY Harmony Biosciences Holdings, Inc. | MOption exercise Stock Optionderivative10b5-1 | -20,000 | $0.00 | $0 | 185,000 | Dec 9, 2025 |
| Nov 21, 2025 | HRMY Harmony Biosciences Holdings, Inc. | SOpen-market sale Common Stock10b5-1 | -3,427 | $35.00 | $120k | 0 | Nov 25, 2025 |
| Sep 30, 2025 | HRMY Harmony Biosciences Holdings, Inc. | MOption exercise Common Stock | +45,000 | $0.00 | $0 | 45,000 | Oct 2, 2025 |
| Sep 30, 2025 | HRMY Harmony Biosciences Holdings, Inc. | FTax withholding Common Stock | -24,039 | $27.56 | $663k | 20,961 | Oct 2, 2025 |
| Sep 30, 2025 | HRMY Harmony Biosciences Holdings, Inc. | MOption exercise Restricted Stock Unitsderivative | -45,000 | $0.00 | $0 | 45,000 | Oct 2, 2025 |
| Aug 15, 2025 | HRMY Harmony Biosciences Holdings, Inc. | SOpen-market sale Common Stock10b5-1 | -21,573 | $36.50 | $787k | 0 | Aug 19, 2025 |
| May 28, 2025 | PASG Passage BIO, Inc. | AGrant or award Director Stock Option (right to buy)derivative | +201,857 | $0.00 | $0 | 201,857 | May 30, 2025 |
| Apr 1, 2025 | HRMY Harmony Biosciences Holdings, Inc. | SOpen-market sale Common Stock10b5-1 | -6,247 | $32.48 | $203k | 740 | Apr 3, 2025 |
| Apr 1, 2025 | HRMY Harmony Biosciences Holdings, Inc. | SOpen-market sale Common Stock10b5-1 | -740 | $33.12 | $25k | 0 | Apr 3, 2025 |
| Mar 29, 2025 | HRMY Harmony Biosciences Holdings, Inc. | MOption exercise Common Stock | +15,000 | $0.00 | $0 | 15,000 | Apr 1, 2025 |
| Mar 29, 2025 | HRMY Harmony Biosciences Holdings, Inc. | FTax withholding Common Stock | -8,014 | $33.19 | $266k | 6,986 | Apr 1, 2025 |
| Mar 29, 2025 | HRMY Harmony Biosciences Holdings, Inc. | MOption exercise Restricted Stock Unitsderivative | -15,000 | $0.00 | $0 | 15,000 | Apr 1, 2025 |
| Jan 24, 2025 | HRMY Harmony Biosciences Holdings, Inc. | MOption exercise Common Stock10b5-1 | +3,812 | $0.00 | $0 | 3,812 | Jan 28, 2025 |
| Jan 24, 2025 | HRMY Harmony Biosciences Holdings, Inc. | FTax withholding Common Stock10b5-1 | -2,037 | $38.01 | $77k | 1,775 | Jan 28, 2025 |
| Jan 27, 2025 | HRMY Harmony Biosciences Holdings, Inc. | SOpen-market sale Common Stock10b5-1 | -1,775 | $38.05 | $68k | 0 | Jan 28, 2025 |
| Jan 24, 2025 | HRMY Harmony Biosciences Holdings, Inc. | MOption exercise Restricted Stock Unitsderivative10b5-1 | -3,812 | $0.00 | $0 | 11,438 | Jan 28, 2025 |
| Jan 25, 2025 | HRMY Harmony Biosciences Holdings, Inc. | AGrant or award Stock Optionderivative10b5-1 | +66,250 | $0.00 | $0 | 66,250 | Jan 28, 2025 |
| Jan 25, 2025 | HRMY Harmony Biosciences Holdings, Inc. | AGrant or award Restricted Stock Unitsderivative10b5-1 | +18,900 | $0.00 | $0 | 18,900 | Jan 28, 2025 |
| Jan 21, 2025 | HRMY Harmony Biosciences Holdings, Inc. | MOption exercise Common Stock10b5-1 | +25,000 | $29.03 | $726k | 25,000 | Jan 23, 2025 |
| Jan 21, 2025 | HRMY Harmony Biosciences Holdings, Inc. | SOpen-market sale Common Stock10b5-1 | -25,000 | $40.18 | $1.0M | 0 | Jan 23, 2025 |
| Jan 21, 2025 | HRMY Harmony Biosciences Holdings, Inc. | MOption exercise Stock Optionderivative10b5-1 | -25,000 | $0.00 | $0 | 205,000 | Jan 23, 2025 |
Questions about Sandip Kapadia
Answered from the filings on this page, as of the latest one.
Is Sandip Kapadia buying or selling?
In the last 12 months Sandip Kapadia reported 0 open-market buys worth $0 and 4 open-market sells worth $1.8M on SEC Form 4; the latest was sold $139k of HRMY on Jan 26, 2026. Grants, option exercises and tax withholding are not counted.
How did Sandip Kapadia's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Sandip Kapadia has 0.
Where does Sandip Kapadia file Form 4?
Sandip Kapadia has filed Form 4 at HRMY (Harmony Biosciences Holdings, Inc.) as CHIEF FINANCIAL OFFICER; PASG (Passage BIO, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.